Usability of a new disposable autoinjector platform device: Results of a formative study conducted with a broad user population

Medical Devices: Evidence and Research

Volumn 8, Issue , 2015, Pages 255-264

  Lange, Jakob ^a   Richard, Philipp ^a   Bradley, Nick ^b  

^a The Development of New Drug Delivery Devices and Digital Business Models at Ypsomed   (Switzerland)

^b Bergo   (United Kingdom)

Author keywords

Autoinjector; Handling study; Human factors engineering; Instructions for use; Use error; YpsoMate

Indexed keywords

HUMAN ENGINEERING;

AUTOINJECTOR; BIOPHARMACEUTICALS; DEGREE OF CONFIDENCE; HANDLING STUDY; INSTRUCTIONS FOR USE; USABILITY STUDIES; USE ERRORS; USER CHARACTERISTICS;

USABILITY ENGINEERING;

ADULT; AGED; ARTICLE; AUTOINJECTOR; CLINICAL EFFECTIVENESS; COMFORT; CONTROLLED STUDY; DEVICE SAFETY; DISPOSABLE EQUIPMENT; FEMALE; HUMAN; MALE; PERSONAL EXPERIENCE; SATISFACTION; SYSTEMATIC ERROR; TREATMENT DURATION;

EID: 84936943050     PISSN: None     EISSN: 11791470     Source Type: Journal    
DOI: 10.2147/MDER.S85938     Document Type: Article

References (34)

1. French DL, Collins JJ. Advances in parenteral injection devices and aids. In: Pharmaceutical Dosage Forms, Parenteral Medications, Vol 3: Regulations, Validation and the Future. 3rd ed. London, UK: Informa Healthcare; 2010:71-75.
2. Thompson I, Lange J. Pen and autoinjector drug delivery devices. In: Kolhe P, Shah M, Rathore N, editors. Sterile Product Development, AAPS Advances in the Pharmaceutical Sciences Series 6. New York, NY: Springer; 2013:331-356.
3. Willis H, Webster J, Larkin AM, Parkes L. An observational, retrospective, UK and Ireland audit of patient adherence to subcutaneous interferon beta-1a injections using the Rebismart® injection device. Patient Prefer Adherence. 2014;8:843-851.
4. Boeru G, Milanov I, De Robertis F, et al. Extaviject® 30G device for subcutaneous self-injection of interferon beta-1b for multiple sclerosis: a prospective European study. Med Devices. 2013;6:175-184.
5. Seddighzadeh A, Hung S, Selmaj K, et al. Single use autoinjector for peginterferon-β1a treatment of relapsing-remitting multiple sclerosis: safety, tolerability and patient evaluation data from the Phase IIIb ATTAIN study. Expert Opin Drug Deliv. 2014;11:1713-1720.
6. Devonshire V, Arbizu T, Borre B, et al. Patient-rated suitability of a novel electronic device for self-injection of subcutaneous interferon beta-1a in relapsing multiple sclerosis: an international, single-arm, multicentre, Phase IIIb study. BMC Neurol. 2010;10:28.
7. Wray S, Armstrong R, Herrman CV, et al. Results from the single-use autoinjector for self-administration of subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis (MOSAIC) study. Expert Opin Drug Deliv. 2011;8:1543-1553.
8. Berteau C, Schwarzenbach F, Donazzolo Y, et al. Evaluation of performance, safety, subject acceptance, and compliance of a disposable autoinjector for subcutaneous injections in healthy volunteers. Patient Prefer Adherence. 2010;4:379-388.
9. Phillips JT, Fox E, Grainger W, Tuccillo D, Liu S, Deykin A. An open-label, multicentre study to evaluate the safe and effective use of the single-use autoinjector with an Avonex® prefilled syringe in multiple sclerosis subjects. BMC Neurol. 2011;11:126.
10. Pachon JA, Kivitz AJ, Heuer K-U, Pichlmeyer U. Assessing usability, label comprehension, pen robustness and pharmacokinetics of a self-administered prefilled autoinjector pen of methotrexate in patients with rheumatoid arthritis. SAGE Open Med. 2014;2:1-12.
11. Thompson I. Matching a range of injectors with both patients' and pharma partners' needs. ONdrugDelivery Mag. 2012;(33):36-38. Available from: http://www.ondrugdelivery.com/publications/Injectable%20Devices%202012/Ypsomed.pdf. Accessed April 1, 2015.
12. Association for the Advancement of Medical Instrumentation. Human Factors Engineering - Design of Medical Devices. ANSI/AAMI HE75:2009. Arlington, USA: Association for the Advancement of Medical Instrumentation; 2010.
13. International Standards Organisation. Medical Devices - Application of Usability Engineering to Medical Devices. ISO 62366:2015. Geneva, Switzerland: International Standards Organisation; 2015.
14. Draft Guidance for Industry and Food and Drug Administration Staff. Applying Human Factors and Usability Engineering to Optimize Medical Device Design. Silver Spring, MD: Food and Drug Administration; 2011. Available from: http://www.fda.gov/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm259748.htm. Accessed April 1, 2015.
15. Wiklund M, Kendler J, Strochlic AY. Usability Testing of Medical Devices, Boca Raton, FL: CRC Press, Taylor & Francis Group; 2011.
16. Lange J, Richard P, Bradley N. Usability of devices for self-injection: results of a formative study on a new disposable pen injector. Med Devices. 2014;7:195-203.
17. Guerlain S, Hugine A, Wang L. A comparison of 4 epinephrine autoinjector delivery systems: usability and patient preference. Ann Allergy Asthma Immunol. 2010;104:172-177.
18. Guerlain S, Wang L, Hugine A. Intelliject's novel epinephrine autoinjector: sharps injury prevention validation and comparable analysis with EpiPen and Twinject. Ann Allergy Asthma Immunol. 2010;105:480-484.
19. Schwarzenbach F, Dao Trong M, Grange L, et al. Evaluation of performance, safety, subject acceptance, and compliance of a disposable autoinjector for subcutaneous injections in healthy volunteers. Patient Prefer Adherence. 2014;8:199-209.
20. Edwards ES, Edwards ET, Gunn R, Patterson P, North R. Design validation and labeling comprehension study for a new epinephrine autoinjector. Ann Allergy Asthma Immunol. 2013;110:189-193.
21. YpsoMate™ - The 2-step autoinjector [Product description]. Burgdorf, Switzerland: Ypsomed AG; 2014. Available from: http://www.ypsomed.com/files/documents-ypsomed/yds-downloads/Ypsomed-YpsoMate-Brochure.pdf. Accessed April 1, 2015.
22. Lombardelli S. Adrenaline auto-injectors: how effective are written patient instructions when used alone in a simulated self-administration test? Poster presented at: 29th Congress of the European Academy of Allergy and Clinical Immunology, June 5-9, 2010, London. Available from: http://www.life-saver.org/wordpress/wp-content/uploads/2010/08/Lombardelli-poster-EAACI-2010.pdf. Accessed April 1, 2015.
23. Avonex Pen [instructions for use]. Cambridge, MA: Biogen Idec; 2014. Available from: https://www.avonex.com/pdfs/AVONEX-pen.pdf. Accessed April 1, 2015.
24. Humira Autoinjector [instructions for use]. North Chicago, IL: Abbvie; 2014. Available from: http://www.rxabbvie.com/pdf/humirapen_PIL.pdf. Accessed April 1, 2015.
25. Enbrel SureClick Autoinjector [Instructions for use]. Thousand Oaks, CA: Immunex; 2013. Available from: http://pi.amgen.com/united_states/enbrel/derm/enbrel_piu.pdf. Accessed April 1, 2015.
26. Rebif Rebidose [instructions for use]. Rockland, MA: EMD Serono; 2012. Available from: http://www.rebif.com/resources/pdf/Rebif%20Rebidose%20IFU_Final.pdf. Accessed April 1, 2015.
27. EpiPen [patient information]. Morgantown, WV: Mylan; 2014. Available from: https://www.epipen.com/en/prescribing-information#Patient. Accessed April 1, 2015.
28. Evzio Autoinjector [patient information]. Richmond, VA: kaleo; 2014. Available from: http://www.evzio.com/pdfs/Evzio-Patient-Information.pdf. Accessed April 1, 2015.
29. Simponi SmartJect autoinjector [instructions for use]. Horsham, PA: Janssen Biotech; 2013. Available from: http://www.simponi.com/shared/product/simponi/medication-guide.pdf. Accessed April 1, 2015.
30. Pegasys Proclick autoinjector [self-injection training guide]. South San Francisco, CA: Genentech; 2011. Available from: http://prod.pegasys.gene.s3.amazonaws.com/downloads/proClick-guide.pdf. Accessed on April 1, 2015.
31. Trulicity (dulaglutide) single dose pen [instructions for use]. Indianapolis, IN: Eli Lilly; 2014. Available from: http://pi.lilly.com/us/trulicity-lowdose-ai-ifu.pdf. Accessed April 1, 2015.
32. Aranesp SureClick Autoinjector [patient instructions for use]. Thousand Oaks, CA: Amgen; 2008. Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/103951s5197AranespPIUAutoinjector.pdf. Accessed April 1, 2015.
33. Baker TW, Webber CM, Stolfi A, Gonzalez-Reyes E. The TEN study: time epinephrine needs to reach muscle. Ann Allergy Asthma Immunol. 2011;107:235-238.
34. Lieberman P. The 10-second rule and other myths about epinephrine and autoinjectors. Ann Allergy Asthma Immunol. 2011;107:189-190.